While the debate is theoretical, scientists can weigh possible risks versus the lives they know the vaccine will save. But a recent example of a controversial drug is throwing the issue into the global spotlight in a very real way. In other public health news: clinical trials and ethics; decoding a baby's DNA; home health care workers and infection rates; a new type of self-harm in teenagers; and more.
from Kaiser Health News https://ift.tt/2vFKKS9
April 23, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
Gubernatorial Candidates Quarrel Over Glory for Winning Opioid SettlementsOpioid settlement cash is not inherently political. It’s not the result of a law passed by Congress nor an edit to the state budget. It’s not taxpayer money. Rather, it’s coming from health care companies that were sued for f… Read More
An Arm and a Leg: John Green vs. Johnson & Johnson (Part 2)The final episode of this two-part series about YouTube star John Green and his fight to make tuberculosis drugs more affordable takes listeners halfway around the world to India. For nearly two decades, activists there… Read More
The AMA May Reconsider Single-Payer Health CareIs the American Medical Association going soft on single-payer health care? We’re about to find out. For more than a century, the most influential U.S. physician group has stridently opposed what could generally be described … Read More
Dads Drive Growth in California’s Paid Family Leave ProgramIn a sign of growing domestic equality, more new dads are claiming paid family leave to bond with their babies and support their partners during the first weeks of parenthood. In California, which has one of the nation’s olde… Read More
When That Supposedly Free Annual Physical Generates a BillChristine Rogers of Wake Forest, North Carolina, didn’t hesitate when she was asked to fill out a routine mental health questionnaire during a checkup last November. Her answers on the form led her primary care doctor to ask … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment